Profire, B.-Ș.; Lupașcu, F.G.; Sava, A.; Turin-Moleavin, I.-A.; Bejan, D.; Stătescu, C.; Șorodoc, V.; Sascău, R.-A.; Șorodoc, L.; Pinteala, M.;
et al. SGLT2 Inhibitors and Curcumin Co-loaded Liposomal Formulations as Synergistic Delivery Systems for Heart Failure Therapy. Pharmaceutics 2025, 17, 969.
https://doi.org/10.3390/pharmaceutics17080969
AMA Style
Profire B-Ș, Lupașcu FG, Sava A, Turin-Moleavin I-A, Bejan D, Stătescu C, Șorodoc V, Sascău R-A, Șorodoc L, Pinteala M,
et al. SGLT2 Inhibitors and Curcumin Co-loaded Liposomal Formulations as Synergistic Delivery Systems for Heart Failure Therapy. Pharmaceutics. 2025; 17(8):969.
https://doi.org/10.3390/pharmaceutics17080969
Chicago/Turabian Style
Profire, Bianca-Ștefania, Florentina Geanina Lupașcu, Alexandru Sava, Ioana-Andreea Turin-Moleavin, Dana Bejan, Cristian Stătescu, Victorița Șorodoc, Radu-Andy Sascău, Laurențiu Șorodoc, Mariana Pinteala,
and et al. 2025. "SGLT2 Inhibitors and Curcumin Co-loaded Liposomal Formulations as Synergistic Delivery Systems for Heart Failure Therapy" Pharmaceutics 17, no. 8: 969.
https://doi.org/10.3390/pharmaceutics17080969
APA Style
Profire, B.-Ș., Lupașcu, F. G., Sava, A., Turin-Moleavin, I.-A., Bejan, D., Stătescu, C., Șorodoc, V., Sascău, R.-A., Șorodoc, L., Pinteala, M., & Profire, L.
(2025). SGLT2 Inhibitors and Curcumin Co-loaded Liposomal Formulations as Synergistic Delivery Systems for Heart Failure Therapy. Pharmaceutics, 17(8), 969.
https://doi.org/10.3390/pharmaceutics17080969
